These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5361831)

  • 21. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():143-51. PubMed ID: 4510911
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 23. europhysiological study of dipossium chlorazepate (4306 CB).
    Mercier J; Dessagne S; Manez J
    Arzneimittelforschung; 1970 Jan; 20(1):125-7. PubMed ID: 5467435
    [No Abstract]   [Full Text] [Related]  

  • 24. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs].
    Utkin VV
    Probl Tuberk; 1973; 51(1):12-6. PubMed ID: 4727151
    [No Abstract]   [Full Text] [Related]  

  • 27. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis].
    Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP
    Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood bacteriostatic activity in pulmonary tuberculosis patients undergoing treatment with drugs of the 1st and 2d series].
    Alekseevskaia KP
    Probl Tuberk; 1972; 50(6):48-52. PubMed ID: 5051126
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of pabophen on the bioelectric activity of the brain].
    Nikiforov MI; Azhubalis VA; Generalov BI
    Farmakol Toksikol; 1968; 31(6):647-50. PubMed ID: 5713573
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 36. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of adolescents with various forms of tuberculosis using 2d-series tuberculostatic preparations].
    Rushchak VA
    Vrach Delo; 1971 Oct; 10():90-2. PubMed ID: 5316836
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of morphine on the bioelectric activity of the brain in chronic pain].
    Danilov GE
    Farmakol Toksikol; 1967; 30(2):138-9. PubMed ID: 5599511
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tuberculostatic preparations of the 2d series in the treatment of chronic forms of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushak VA
    Probl Tuberk; 1972; 50(6):38-41. PubMed ID: 4538124
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the effect of tuberculostatics on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H; Kalich R
    Naturwissenschaften; 1966 Apr; 53(8):209-10. PubMed ID: 5990085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.